Cargando…

Mitochondrial Bioenergetics Is Altered in Fibroblasts from Patients with Sporadic Alzheimer's Disease

The identification of an early biomarker to diagnose Alzheimer's disease (AD) remains a challenge. Neuropathological studies in animal and AD patients have shown that mitochondrial dysfunction is a hallmark of the development of the disease. Current studies suggest the use of peripheral tissues...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez, María J., Ponce, Daniela P., Osorio-Fuentealba, Cesar, Behrens, Maria I., Quintanilla, Rodrigo A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635042/ https://www.ncbi.nlm.nih.gov/pubmed/29056898 http://dx.doi.org/10.3389/fnins.2017.00553

Ejemplares similares

Mitochondrial permeability transition pore contributes to mitochondrial dysfunction in fibroblasts of patients with sporadic Alzheimer's disease
por: Pérez, María José, et al.
Publicado: (2018)

Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease
por: Cabezas-Opazo, Fabian A., et al.
Publicado: (2015)

Truncated Tau Induces Mitochondrial Transport Failure Through the Impairment of TRAK2 Protein and Bioenergetics Decline in Neuronal Cells
por: Quintanilla, Rodrigo A., et al.
Publicado: (2020)

Mitochondrial Dynamics and Bioenergetic Alteration During Inflammatory Activation of Astrocytes
por: Rahman, Md Habibur, et al.
Publicado: (2020)

Insulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages
por: Neth, Bryan J., et al.
Publicado: (2017)

Mitochondrial Metabolism in Astrocytes Regulates Brain Bioenergetics, Neurotransmission and Redox Balance
por: Rose, Jordan, et al.
Publicado: (2020)

New Implications for the Melanocortin System in Alcohol Drinking Behavior in Adolescents: The Glial Dysfunction Hypothesis
por: Orellana, Juan A., et al.
Publicado: (2017)

Plasma glycocholic acid and linoleic acid identified as potential mediators of mitochondrial bioenergetics in Alzheimer’s dementia
por: Amick, K. Allison, et al.
Publicado: (2022)

Relationship Between Mitochondrial Structure and Bioenergetics in Pseudoxanthoma elasticum Dermal Fibroblasts
por: Lofaro, Francesco Demetrio, et al.
Publicado: (2020)

Neuronal Mitochondrial Dysfunction and Bioenergetic Failure in Inflammation-Associated Depression
por: Casaril, Angela Maria, et al.
Publicado: (2021)

ATP Synthase and Mitochondrial Bioenergetics Dysfunction in Alzheimer’s Disease
por: Patro, Somya, et al.
Publicado: (2021)

Mitochondrial bioenergetics in ocular fibroblasts of two myasthenia gravis cases
por: Europa, Tarin A., et al.
Publicado: (2022)

Bioenergetic Dysfunction and Inflammation in Alzheimer’s Disease: A Possible Connection
por: Wilkins, Heather M., et al.
Publicado: (2014)

Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration
por: Pérez, María J., et al.
Publicado: (2018)

Dysfunctional Mitochondrial Bioenergetics and Synaptic Degeneration in Alzheimer Disease
por: Tang, Jason, et al.
Publicado: (2019)

Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer’s Disease
por: Arnst, Nikita, et al.
Publicado: (2022)

Anandamide Effects in a Streptozotocin-Induced Alzheimer’s Disease-Like Sporadic Dementia in Rats
por: Moreira-Silva, Daniel, et al.
Publicado: (2018)

Alterations in Mitochondrial Quality Control in Alzheimer’s Disease
por: Cai, Qian, et al.
Publicado: (2016)

Visual-spatial processing impairment in the occipital-frontal connectivity network at early stages of Alzheimer’s disease
por: Plaza-Rosales, Iván, et al.
Publicado: (2023)

ANT2-defective fibroblasts exhibit normal mitochondrial bioenergetics
por: Prabhu, Dolly, et al.
Publicado: (2015)

Mitochondrial fission and bioenergetics mediate human lung fibroblast durotaxis
por: Guo, Ting, et al.
Publicado: (2023)

Remodelling of the Mitochondrial Bioenergetic Pathways in Human Cultured Fibroblasts with Carbohydrates
por: Protasoni, Margherita, et al.
Publicado: (2023)

Mitochondrial Dysfunction in Alzheimer’s Disease and the Rationale for Bioenergetics Based Therapies
por: Onyango, Isaac G., et al.
Publicado: (2016)

Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer's disease
por: Onyango, Isaac G.
Publicado: (2018)

Nicotinamide, a Poly [ADP-Ribose] Polymerase 1 (PARP-1) Inhibitor, as an Adjunctive Therapy for the Treatment of Alzheimer’s Disease
por: Salech, Felipe, et al.
Publicado: (2020)

Concentration dependent effect of calcium on brain mitochondrial bioenergetics and oxidative stress parameters
por: Pandya, Jignesh D., et al.
Publicado: (2013)

Cancer Imprints an Increased PARP-1 and p53-Dependent Resistance to Oxidative Stress on Lymphocytes of Patients That Later Develop Alzheimer's Disease
por: Salech, Felipe, et al.
Publicado: (2018)

Ketones Elicit Distinct Alterations in Adipose Mitochondrial Bioenergetics
por: Walton, Chase M., et al.
Publicado: (2020)

Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease
por: Bellanti, Francesco, et al.
Publicado: (2022)

Microbiome-Mediated Upregulation of MicroRNA-146a in Sporadic Alzheimer’s Disease
por: Zhao, Yuhai, et al.
Publicado: (2018)

Data-Driven Sequence of Changes to Anatomical Brain Connectivity in Sporadic Alzheimer’s Disease
por: Oxtoby, Neil P., et al.
Publicado: (2017)

Features of Postnatal Hippocampal Development in a Rat Model of Sporadic Alzheimer’s Disease
por: Rudnitskaya, Ekaterina A., et al.
Publicado: (2020)

Mitochondrial Bioenergetics in Different Pathophysiological Conditions
por: Valenti, Daniela, et al.
Publicado: (2021)

Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID‐19 pneumonia
por: Gibellini, Lara, et al.
Publicado: (2020)

Link between the unfolded protein response and dysregulation of mitochondrial bioenergetics in Alzheimer’s disease
por: Poirier, Yannik, et al.
Publicado: (2019)

Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease
por: Austad, Steven N., et al.
Publicado: (2022)

Disruption of Glucose Metabolism in Aged Octodon degus: A Sporadic Model of Alzheimer's Disease
por: Cisternas, Pedro, et al.
Publicado: (2021)

Mitochondrial Bioenergetics and Dynamism in the Failing Heart
por: Morciano, Giampaolo, et al.
Publicado: (2021)

Gentamicin Affects the Bioenergetics of Isolated Mitochondria and Collapses the Mitochondrial Membrane Potential in Cochlear Sensory Hair Cells
por: O’Reilly, Molly, et al.
Publicado: (2019)

Therapeutic Actions of the Thiazolidinediones in Alzheimer's Disease
por: Pérez, María José, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r1lc3be7fsdr9ij0sh7q4rqa1t